Loading...
QUCY logo

Quantum Cyber N.V.NasdaqCM:QUCY Stock Report

Market Cap US$21.7m
Share Price
US$2.12
US$14
84.9% undervalued intrinsic discount
1Y30.9%
7D1.0%
1D
Portfolio Value
View

Quantum Cyber N.V.

NasdaqCM:QUCY Stock Report

Market Cap: US$21.7m

QUCY Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Quantum Cyber N.V. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Quantum Cyber
Historical stock prices
Current Share PriceUS$2.12
52 Week HighUS$4.93
52 Week LowUS$0.30
Beta2.23
1 Month Change-38.73%
3 Month Change272.65%
1 Year Change30.86%
3 Year Change-98.91%
5 Year Changen/a
Change since IPO-99.47%

Recent News & Updates

Recent updates

Seeking Alpha Sep 07

Mainz Biomed GAAP EPS of -$0.91, revenue of $0.24M beats by $0.14M

Mainz Biomed press release (NASDAQ:MYNZ): 1H GAAP EPS of -$0.91. Revenue of $0.24M (-42.9% Y/Y) beats by $0.14M. Mid-year cash balance of $26M.
Seeking Alpha Aug 16

Mainz Biomed stock rises 22% on launch of colorectal cancer test in Italy, UAE

Mainz Biomed (NASDAQ:MYNZ) said its colorectal cancer detection test ColoAlert was now comercially available in Italy and the United Arab Emirates (UAE). In May, Mainz partnered with Dante Genomics to commercialize the at-home  detection test for colorectal cancer. The company added that the product was currently being commercialized across Europe and select international markets. With the ColoAlert test CE-IVD certified and patient collection kit CE marked to IVDR requirements, ColoAlert will now be marketed through Dante's database and sold via Dante's, region-specific, ecommerce websites, Mainz noted in an Aug. 16 press release. MYNZ  +21.53% to $11.29 premarket Aug. 16
Seeking Alpha Jan 26

Mainz Biomed: Sharp Appreciation In Value Since IPO

Mainz Biomed has filed Form F-1 to raise ~$41 million gross proceeds from 1.5M shares. The company has initiated various steps towards FDA approval of its lead product. The company offers an attractive opportunity with a fraction of the market capitalization of its main competitor.

Shareholder Returns

QUCYUS BiotechsUS Market
7D1.0%2.5%2.2%
1Y30.9%28.7%24.8%

Return vs Industry: QUCY exceeded the US Biotechs industry which returned 28.7% over the past year.

Return vs Market: QUCY exceeded the US Market which returned 24.8% over the past year.

Price Volatility

Is QUCY's price volatile compared to industry and market?
QUCY volatility
QUCY Average Weekly Movement96.9%
Biotechs Industry Average Movement10.4%
Market Average Movement7.2%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: QUCY's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: QUCY's weekly volatility has increased from 50% to 97% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a12David Lazarquantum-cyber.ai

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets.

Quantum Cyber N.V. Fundamentals Summary

How do Quantum Cyber's earnings and revenue compare to its market cap?
QUCY fundamental statistics
Market capUS$21.65m
Earnings (TTM)-US$15.93m
Revenue (TTM)US$537.08k
49.4x
P/S Ratio
-1.7x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QUCY income statement (TTM)
RevenueUS$537.08k
Cost of RevenueUS$147.29k
Gross ProfitUS$389.79k
Other ExpensesUS$16.32m
Earnings-US$15.93m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-1.27
Gross Margin72.58%
Net Profit Margin-2,965.83%
Debt/Equity Ratio2.8%

How did QUCY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/15 09:30
End of Day Share Price 2026/06/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum Cyber N.V. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael OkunewitchMaxim Group